Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

Clinical trial NCT02926768 · COMPLETED

Trial details

NCT number: NCT02926768
Sponsor: Checkpoint Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Neoplasms Carcinoma, Non-Small-Cell Lung Lung Diseases Adenocarcinoma

Start date: 2016-09-01
Primary completion: 2020-09-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.